Api Details

Rivaroxaban is a pharmaceutical API primarily used as an anticoagulant medication to prevent blood clots in conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), and atrial fibrillation. It belongs to the class of direct oral anticoagulants (DOACs) and works by inhibiting the activity of factor Xa, thereby preventing the formation of blood clots. Rivaroxaban is administered orally, with dosages varying based on individual response and the specific indication being treated. While generally well-tolerated, potential side effects may include bleeding, bruising, and gastrointestinal discomfort. Regulatory adherence ensures stringent quality and safety standards during manufacturing, ensuring reliability in Rivaroxaban-containing pharmaceutical products.